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The strength of recombinant gene expression is a key
property of cell lines for biopharmaceutical protein pro-
duction. In most stable cell lines the expression vector
is stably introduced into the host chromosomal DNA.
Apart from the copy number and the used expression
control elements the performance of recombinant
expression vectors is modulated by genetic and epige-
netic features provided by flanking host elements. Since
targeted integration is very difficult cell clones with high
expression of a recombinant vector are created by ran-
dom integration and large scale screening for gene
expression. This allows the isolation of those rare
recombinant cells in which gene expression is optimal.
This is usually due to locus-specific influences of the
chromosomal surroundings.
We have developed an efficient methodology for tar-
geting expression cassettes to specific chromosomal sites
[1,2]]. The method (Flp recombinase mediated cassette
exchange - RMCE) allows the repeated use of defined
loci by targeting constructs for expression of proteins
and viruses, thereby allowing to exploit the positive fea-
tures of a given integration site [3,4]]. Thereby, a sys-
tematic evaluation of the performance of a set of
expression vectors in various chromosomal sites
becomes feasible.
In this study we screened for high performance inte-
gration sites in HEK293 and CHO-K1 cells supporting
expression cassettes driven by a potent promoter. As a
read out, production of antibodies and recombinant ret-
roviral vectors were used. Thereby, we could show that
high level expression of a given promoter is restricted to
defined integration sites, while other sites show only
moderate expression (data not shown). An important
new finding was that a given chromosomal site is not
flexible with respect to the integrated cassette but
requires the integration of specific promoters. As illu-
strated in figure 1, an integration site, identified for sup-
porting high level expression of an SV40 promoter
driven cassette fails to adequately support expression of
MPSV and adenoviral major late promoter (AdmlP).
Vice versa, another site, initially screened for supporting
MSCV promoter expression, could restore expression of
the highly homologous MPSV promoter while the SV40
promoter and the AdmlP promoter give only moderate
expression.
Finally, we tested the impact of the orientation of the
cassette in a specific chromosomal site. We found that
some integration sites are flexible with respect to the
orientation of the expression cassettes while others sup-
port expression only in one direction (data not shown).
While classical enhancer elements are known to acti-
vate promoters largely independent from the relative
position this finding suggests that other cis acting ele-
ments affect the incoming cassettes in an orientation
dependent manner. Together, this shows that not the
nature of integration site and the design of the vector as
such define the performance of a producer cell clone.
Rather, the interplay between these components defines
the level and stability of expression. Since these interac-
tions cannot be predicted, the performance of a vector
in a given site has to be evaluated empirically.
In order to exploit favourable sets of chromosomal
sites and vectors we made use of bacterial artificial chro-
mosome (BAC) vectors. By recombineering, expression
cassettes were integrated into pre-selected chromosomal
sites as encoded by BAC vectors. These vectors were
randomly integrated into cells by standard transfection
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protocols. Clones were isolated and evaluated for
expression. As expected, highly reproducible expression
characteristics were found in individual clones (data not
shown). In conclusion, the definition of favorable combi-
nations of specific integration sites and vector design
allow the rational exploitation of given chromosomal
sites. For this purpose, technologies for site specific
genetic manipulation of mammalian cells are essential.
This concerns both targeted integration of expression
cassettes into defined loci (such as RMCE or site specific
nuclease induced homologous recombination) or by
transduction of large chromosomal domains (as pro-
vided by BAC vectors). These technologies pave the way
for predictable and high expression of biotechnologically
relevant products such as antibodies and recombinant
viral vectors.
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Figure 1 Mode of tagging defines the optimal targeting cassette. Two highly potent chromosomal integration sites were screened upon
random integration of an expression cassette driven by the SV40 promoter and the MSCV promoter, respectively. By means of Flp recombinase
mediated cassette exchange, the screening cassette was exchanged for various expression cassettes, thereby integrating expression cassettes
driven by the SV40 promoter, the adenoviral major late promoter (AdmLP) or the MPSV promoter into the same chromosomal site. The
expression level upon targeting the various cassettes was determined and related to the expression level of the tagged cell.
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